Identification of Novel Carbonic Anhydrase IX Inhibitors Using High-Throughput Screening of Pooled Compound Libraries by DNA-Linked Inhibitor Antibody Assay (DIANA)
The DNA-linked inhibitor antibody assay (DIANA) has been recently validated for ultrasensitive enzyme detection and for quantitative evaluation of enzyme inhibitor potency. Here we present its adaptation for high-throughput screening of human carbonic anhydrase IX (CAIX), a promising drug and diagno...
Saved in:
| Published in | SLAS discovery Vol. 25; no. 9; pp. 1026 - 1037 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Los Angeles, CA
SAGE Publications
01.10.2020
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 2472-5552 2472-5560 2472-5560 |
| DOI | 10.1177/2472555220918836 |
Cover
| Abstract | The DNA-linked inhibitor antibody assay (DIANA) has been recently validated for ultrasensitive enzyme detection and for quantitative evaluation of enzyme inhibitor potency. Here we present its adaptation for high-throughput screening of human carbonic anhydrase IX (CAIX), a promising drug and diagnostic target. We tested DIANA’s performance by screening a unique compound collection of 2816 compounds consisting of lead-like small molecules synthesized at the Institute of Organic Chemistry and Biochemistry (IOCB) Prague (“IOCB library”). Additionally, to test the robustness of the assay and its potential for upscaling, we screened a pooled version of the IOCB library. The results from the pooled screening were in agreement with the initial nonpooled screen with no lost hits and no false positives, which shows DIANA’s potential to screen more than 100,000 compounds per day.
All DIANA screens showed a high signal-to-noise ratio with a Z′ factor of >0.89. The DIANA screen identified 13 compounds with Ki values equal to or better than 10 µM. All retested hits were active also in an orthogonal enzymatic assay showing zero false positives. However, further biophysical validation of identified hits revealed that the inhibition activity of several hits was caused by a single highly potent CAIX inhibitor, being present as a minor impurity. This finding eventually led us to the identification of three novel CAIX inhibitors from the screen. We confirmed the validity of these compounds by elucidating their mode of binding into the CAIX active site by x-ray crystallography. |
|---|---|
| AbstractList | The DNA-linked inhibitor antibody assay (DIANA) has been recently validated for ultrasensitive enzyme detection and for quantitative evaluation of enzyme inhibitor potency. Here we present its adaptation for high-throughput screening of human carbonic anhydrase IX (CAIX), a promising drug and diagnostic target. We tested DIANA's performance by screening a unique compound collection of 2816 compounds consisting of lead-like small molecules synthesized at the Institute of Organic Chemistry and Biochemistry (IOCB) Prague ("IOCB library"). Additionally, to test the robustness of the assay and its potential for upscaling, we screened a pooled version of the IOCB library. The results from the pooled screening were in agreement with the initial nonpooled screen with no lost hits and no false positives, which shows DIANA's potential to screen more than 100,000 compounds per day.All DIANA screens showed a high signal-to-noise ratio with a Z' factor of >0.89. The DIANA screen identified 13 compounds with Ki values equal to or better than 10 µM. All retested hits were active also in an orthogonal enzymatic assay showing zero false positives. However, further biophysical validation of identified hits revealed that the inhibition activity of several hits was caused by a single highly potent CAIX inhibitor, being present as a minor impurity. This finding eventually led us to the identification of three novel CAIX inhibitors from the screen. We confirmed the validity of these compounds by elucidating their mode of binding into the CAIX active site by x-ray crystallography.The DNA-linked inhibitor antibody assay (DIANA) has been recently validated for ultrasensitive enzyme detection and for quantitative evaluation of enzyme inhibitor potency. Here we present its adaptation for high-throughput screening of human carbonic anhydrase IX (CAIX), a promising drug and diagnostic target. We tested DIANA's performance by screening a unique compound collection of 2816 compounds consisting of lead-like small molecules synthesized at the Institute of Organic Chemistry and Biochemistry (IOCB) Prague ("IOCB library"). Additionally, to test the robustness of the assay and its potential for upscaling, we screened a pooled version of the IOCB library. The results from the pooled screening were in agreement with the initial nonpooled screen with no lost hits and no false positives, which shows DIANA's potential to screen more than 100,000 compounds per day.All DIANA screens showed a high signal-to-noise ratio with a Z' factor of >0.89. The DIANA screen identified 13 compounds with Ki values equal to or better than 10 µM. All retested hits were active also in an orthogonal enzymatic assay showing zero false positives. However, further biophysical validation of identified hits revealed that the inhibition activity of several hits was caused by a single highly potent CAIX inhibitor, being present as a minor impurity. This finding eventually led us to the identification of three novel CAIX inhibitors from the screen. We confirmed the validity of these compounds by elucidating their mode of binding into the CAIX active site by x-ray crystallography. The DNA-linked inhibitor antibody assay (DIANA) has been recently validated for ultrasensitive enzyme detection and for quantitative evaluation of enzyme inhibitor potency. Here we present its adaptation for high-throughput screening of human carbonic anhydrase IX (CAIX), a promising drug and diagnostic target. We tested DIANA’s performance by screening a unique compound collection of 2816 compounds consisting of lead-like small molecules synthesized at the Institute of Organic Chemistry and Biochemistry (IOCB) Prague (“IOCB library”). Additionally, to test the robustness of the assay and its potential for upscaling, we screened a pooled version of the IOCB library. The results from the pooled screening were in agreement with the initial nonpooled screen with no lost hits and no false positives, which shows DIANA’s potential to screen more than 100,000 compounds per day. All DIANA screens showed a high signal-to-noise ratio with a Z′ factor of >0.89. The DIANA screen identified 13 compounds with Ki values equal to or better than 10 µM. All retested hits were active also in an orthogonal enzymatic assay showing zero false positives. However, further biophysical validation of identified hits revealed that the inhibition activity of several hits was caused by a single highly potent CAIX inhibitor, being present as a minor impurity. This finding eventually led us to the identification of three novel CAIX inhibitors from the screen. We confirmed the validity of these compounds by elucidating their mode of binding into the CAIX active site by x-ray crystallography. The DNA-linked inhibitor antibody assay (DIANA) has been recently validated for ultrasensitive enzyme detection and for quantitative evaluation of enzyme inhibitor potency. Here we present its adaptation for high-throughput screening of human carbonic anhydrase IX (CAIX), a promising drug and diagnostic target. We tested DIANA's performance by screening a unique compound collection of 2816 compounds consisting of lead-like small molecules synthesized at the Institute of Organic Chemistry and Biochemistry (IOCB) Prague ("IOCB library"). Additionally, to test the robustness of the assay and its potential for upscaling, we screened a pooled version of the IOCB library. The results from the pooled screening were in agreement with the initial nonpooled screen with no lost hits and no false positives, which shows DIANA's potential to screen more than 100,000 compounds per day. All DIANA screens showed a high signal-to-noise ratio with a Z' factor of >0.89. The DIANA screen identified 13 compounds with values equal to or better than 10 µM. All retested hits were active also in an orthogonal enzymatic assay showing zero false positives. However, further biophysical validation of identified hits revealed that the inhibition activity of several hits was caused by a single highly potent CAIX inhibitor, being present as a minor impurity. This finding eventually led us to the identification of three novel CAIX inhibitors from the screen. We confirmed the validity of these compounds by elucidating their mode of binding into the CAIX active site by x-ray crystallography. |
| Author | Král, Vlastimil Kugler, Michael Schimer, Jiří Potáček, Milan Tenora, Lukáš Konvalinka, Jan Brynda, Jiří Řezáčová, Pavlína Dejmek, Milan Šácha, Pavel Majer, Pavel Zemanová, Jitka Jahn, Ullrich Navrátil, Václav Tykvart, Jan Hlaváčková, Anna |
| Author_xml | – sequence: 1 givenname: Jan orcidid: 0000-0002-6938-1513 surname: Tykvart fullname: Tykvart, Jan – sequence: 2 givenname: Václav surname: Navrátil fullname: Navrátil, Václav – sequence: 3 givenname: Michael surname: Kugler fullname: Kugler, Michael – sequence: 4 givenname: Pavel surname: Šácha fullname: Šácha, Pavel – sequence: 5 givenname: Jiří surname: Schimer fullname: Schimer, Jiří – sequence: 6 givenname: Anna surname: Hlaváčková fullname: Hlaváčková, Anna – sequence: 7 givenname: Lukáš surname: Tenora fullname: Tenora, Lukáš – sequence: 8 givenname: Jitka surname: Zemanová fullname: Zemanová, Jitka – sequence: 9 givenname: Milan surname: Dejmek fullname: Dejmek, Milan – sequence: 10 givenname: Vlastimil surname: Král fullname: Král, Vlastimil – sequence: 11 givenname: Milan surname: Potáček fullname: Potáček, Milan – sequence: 12 givenname: Pavel surname: Majer fullname: Majer, Pavel – sequence: 13 givenname: Ullrich surname: Jahn fullname: Jahn, Ullrich – sequence: 14 givenname: Jiří surname: Brynda fullname: Brynda, Jiří – sequence: 15 givenname: Pavlína surname: Řezáčová fullname: Řezáčová, Pavlína – sequence: 16 givenname: Jan surname: Konvalinka fullname: Konvalinka, Jan email: jan.konvalinka@uochb.cas.cz |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32452709$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkU1v1DAQhi1UREvpnRPysRwC_kji-BhtKY20WpBoJW6RY082Llk72Ako_6c_lCxb9lAJhHywNX6ed6SZl-jEeQcIvabkHaVCvGepYFmWMUYkLQqeP0Nn-1KSZTk5Ob4zdoouYrwnhFCR8-W8QKecpRkTRJ6hh8qAG21rtRqtd9i3eON_QI9XKjTeWY1L180mqAi4-oor19nGjj5EfBet2-Ibu-2S2y74adsN04i_6ADg9j9L0mfvezB45XeDn5zBa9sEFSxE3Mz4alMma-u-LcAxdWk22sabGZcxqhlfXlXlpnz7Cj1vVR_h4vE-R3fXH25XN8n608dqVa4TzYUck4IKkJITDSJtNW-gNYK3TBmhlSGSg06NKaSBRuU8a3NumExbThkxRWNA8XNED7mTG9T8U_V9PQS7U2GuKan3Q6-fDn1xLg_OEPz3CeJY72zU0PfKgZ_iIpBcpqmUZEHfPKJTswNzzP6zjQUgB0AHH2OA9n_a508UbcffqxyDsv2_xOQgRrWF-t5PwS2j_Tv_CxOKuqE |
| CitedBy_id | crossref_primary_10_1016_j_ejmech_2024_116948 crossref_primary_10_3390_molecules27061894 crossref_primary_10_3390_ijms26020863 crossref_primary_10_1021_acs_chemrev_4c00278 crossref_primary_10_1080_14756366_2022_2052868 crossref_primary_10_1016_j_ejps_2024_106990 |
| Cites_doi | 10.1038/nrd2467 10.1021/acsomega.9b00596 10.1039/C4SC00685B 10.1021/acs.jmedchem.8b01504 10.1016/j.bmc.2013.08.033 10.1038/sj.bjc.6601264 10.1158/0008-5472.CAN-08-2470 10.1073/pnas.0908301106 10.1002/anie.201905209 10.1016/j.tips.2006.09.002 10.1089/ham.2010.1051 10.1038/nrd1877 10.1016/S0021-9258(18)62326-9 10.7717/peerj.4068 10.2146/ajhp120291 10.1021/ol403660w 10.1007/s10555-019-09799-0 10.1002/prot.340040407 10.1021/acs.jmedchem.6b00443 10.1002/jps.2600630107 10.1017/S0033583518000082 10.1093/nar/gkw853 10.1021/jm101541x |
| ContentType | Journal Article |
| Copyright | 2020 Society for Laboratory Automation and Screening |
| Copyright_xml | – notice: 2020 Society for Laboratory Automation and Screening |
| DBID | AAYXX CITATION NPM 7X8 ADTOC UNPAY |
| DOI | 10.1177/2472555220918836 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 2472-5560 |
| EndPage | 1037 |
| ExternalDocumentID | 10.1177/2472555220918836 32452709 10_1177_2472555220918836 10.1177_2472555220918836 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: European Regional Development Fund grantid: OP RDE (No. CZ.02.1.01/0.0/0.0/16_019/0000729) funderid: https://doi.org/10.13039/501100008530 – fundername: Grantová Agentura České Republiky grantid: 17-14510S funderid: https://doi.org/10.13039/501100001824 – fundername: Grantová Agentura České Republiky grantid: 19-10280S funderid: https://doi.org/10.13039/501100001824 – fundername: Ministerstvo Školství, Mládeže a Tělovýchovy grantid: LO1304 funderid: https://doi.org/10.13039/501100001823 |
| GroupedDBID | 0R~ 53G AARDL AAXUO AAYWO ABCCA ABJNI ACDXX ACGFS ACVFH ADBBV ADCNI ADEBD ADVLN AERKM AEUPX AEWDL AEXQZ AFJKZ AFKRG AFPUW AIGII AITUG AJUZI AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ARTOV EBS EJD FDB GROUPED_DOAJ M41 O9- OK1 ROL SBI AALRI AAYXX CITATION ACUIR AIOMO GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION M4V NPM SCNPE 7X8 ADTOC UNPAY |
| ID | FETCH-LOGICAL-c379t-817e9930ce74fc3befd73f2ad7cad093ec4dd89deba635f63d294f3120d8bdea3 |
| IEDL.DBID | UNPAY |
| ISSN | 2472-5552 2472-5560 |
| IngestDate | Tue Aug 19 15:36:02 EDT 2025 Thu Jul 10 19:03:56 EDT 2025 Wed Feb 19 02:29:50 EST 2025 Tue Jul 01 02:39:36 EDT 2025 Thu Apr 24 22:57:52 EDT 2025 Tue Jun 17 22:46:08 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | DNA-linked inhibitor antibody assay carbonic anhydrase IX drug discovery high-throughput screening |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c379t-817e9930ce74fc3befd73f2ad7cad093ec4dd89deba635f63d294f3120d8bdea3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-6938-1513 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://journals.sagepub.com/doi/pdf/10.1177/2472555220918836 |
| PMID | 32452709 |
| PQID | 2406944990 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | unpaywall_primary_10_1177_2472555220918836 proquest_miscellaneous_2406944990 pubmed_primary_32452709 crossref_primary_10_1177_2472555220918836 crossref_citationtrail_10_1177_2472555220918836 sage_journals_10_1177_2472555220918836 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-10-01 |
| PublicationDateYYYYMMDD | 2020-10-01 |
| PublicationDate_xml | – month: 10 year: 2020 text: 2020-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Los Angeles, CA |
| PublicationPlace_xml | – name: Los Angeles, CA – name: United States |
| PublicationTitle | SLAS discovery |
| PublicationTitleAlternate | J Biomol Screen |
| PublicationYear | 2020 |
| Publisher | SAGE Publications |
| Publisher_xml | – name: SAGE Publications |
| References | Kelly, Hackett 2010; 11 Navrátil, Schimer, Tykvart 2017; 45 Krall, Pretto, Neri 2014; 5 Nocentini, Trallori, Singh 2018; 61 Chiche, Ilc, Laferrière 2009; 69 Kapras, Pohl, Císařová 2014; 16 Pacchiano, Carta, McDonald 2011; 54 Kazokaitė, Aspatwar, Parkkila 2017; 5 Pospíšilová, Knedlík, Šácha 2019; 4 Závada, Závadová, Zat’ovičová 2003; 89 Wulf, Matuszewski 2013; 70 Linkuvienė, Zubrienė, Manakova 2018; 51 Thiry, Dogné, Masereel 2006; 27 Clercq, Holý 2005; 4 Pastorekova, Gillies 2019; 38 Mujumdar, Teruya, Tonissen 2016; 59 Hernández-Guerra, Hlavačková, Pramthaisong 2019; 58 Alterio, Hilvo, Fiore 2009; 106 Hsu, Ma, Jun 1974; 63 Pinard, Boone, Rife 2013; 21 Wykoff, Beasley, Watson 2000; 60 Eriksson, Kylsten, Jones 1988; 4 Khalifah 1971; 246 Supuran 2008; 7 Nocentini (10.1177/2472555220918836_bib23) 2018; 61 Hernández-Guerra (10.1177/2472555220918836_bib24) 2019; 58 Clercq (10.1177/2472555220918836_bib16) 2005; 4 Pacchiano (10.1177/2472555220918836_bib7) 2011; 54 Supuran (10.1177/2472555220918836_bib13) 2008; 7 Eriksson (10.1177/2472555220918836_bib22) 1988; 4 Khalifah (10.1177/2472555220918836_bib17) 1971; 246 Pospíšilová (10.1177/2472555220918836_bib18) 2019; 4 Copeland (10.1177/2472555220918836_bib19) 2000 Kazokaitė (10.1177/2472555220918836_bib8) 2017; 5 Mujumdar (10.1177/2472555220918836_bib20) 2016; 59 Chiche (10.1177/2472555220918836_bib5) 2009; 69 Hsu (10.1177/2472555220918836_bib10) 1974; 63 Pinard (10.1177/2472555220918836_bib21) 2013; 21 Kapras (10.1177/2472555220918836_bib25) 2014; 16 Závada (10.1177/2472555220918836_bib4) 2003; 89 Alterio (10.1177/2472555220918836_bib2) 2009; 106 Navrátil (10.1177/2472555220918836_bib15) 2017; 45 Pastorekova (10.1177/2472555220918836_bib1) 2019; 38 Krall (10.1177/2472555220918836_bib9) 2014; 5 Wulf (10.1177/2472555220918836_bib12) 2013; 70 Wykoff (10.1177/2472555220918836_bib3) 2000; 60 Linkuvienė (10.1177/2472555220918836_bib14) 2018; 51 Kelly (10.1177/2472555220918836_bib11) 2010; 11 Thiry (10.1177/2472555220918836_bib6) 2006; 27 |
| References_xml | – volume: 45 start-page: e10 year: 2017 article-title: DNA-Linked Inhibitor Antibody Assay (DIANA) for Sensitive and Selective Enzyme Detection and Inhibitor Screening publication-title: Nucleic Acids Res – volume: 38 start-page: 65 year: 2019 end-page: 77 article-title: The Role of Carbonic Anhydrase IX in Cancer Development: Links to Hypoxia, Acidosis, and Beyond publication-title: Cancer Metastasis Rev – volume: 5 start-page: 3640 year: 2014 end-page: 3644 article-title: A Bivalent Small Molecule-Drug Conjugate Directed against Carbonic Anhydrase IX Can Elicit Complete Tumour Regression in Mice publication-title: Chem. Sci – volume: 51 start-page: e10 year: 2018 article-title: Thermodynamic, Kinetic, and Structural Parameterization of Human Carbonic Anhydrase Interactions toward Enhanced Inhibitor Design publication-title: Q. Rev. Biophys – volume: 58 start-page: 12440 year: 2019 end-page: 12445 article-title: Photochemical C–H Amination of Ethers and Geminal Difunctionalization Reactions in One Pot publication-title: Angew. Chem. Int. Ed – volume: 89 start-page: 1067 year: 2003 end-page: 1071 article-title: Soluble Form of Carbonic Anhydrase IX (CA IX) in the Serum and Urine of Renal Carcinoma Patients publication-title: Br. J. Cancer – volume: 60 start-page: 7075 year: 2000 end-page: 7083 article-title: Hypoxia-Inducible Expression of Tumor-Associated Carbonic Anhydrases publication-title: Cancer Res – volume: 61 start-page: 10860 year: 2018 end-page: 10874 article-title: 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles publication-title: J. Med. Chem – volume: 5 start-page: e4068 year: 2017 article-title: An Update on Anticancer Drug Development and Delivery Targeting Carbonic Anhydrase IX publication-title: PeerJ – volume: 11 start-page: 319 year: 2010 end-page: 323 article-title: Acetazolamide and Sulfonamide Allergy: A Not So Simple Story publication-title: High Alt. Med. Biol – volume: 7 start-page: 168 year: 2008 end-page: 181 article-title: Carbonic Anhydrases: Novel Therapeutic Applications for Inhibitors and Activators publication-title: Nat. Rev. Drug Discov – volume: 4 start-page: 928 year: 2005 end-page: 940 article-title: Acyclic Nucleoside Phosphonates: A Key Class of Antiviral Drugs publication-title: Nat. Rev. Drug Discov – volume: 63 start-page: 27 year: 1974 end-page: 31 article-title: Structure Relationship for Binding of Sulfonamides and Penicillins to Bovine Serum Albumin by Fluorescence Probe Technique publication-title: J. Pharm. Sci – volume: 246 start-page: 2561 year: 1971 end-page: 2573 article-title: Stop-Flow Kinetic Studies on the Native Human Isoenzymes B and C publication-title: J. Biol. Chem – volume: 106 start-page: 16233 year: 2009 end-page: 16238 article-title: Crystal Structure of the Catalytic Domain of the Tumor-Associated Human Carbonic Anhydrase IX publication-title: Proc. Natl. Acad. Sci. U.S.A – volume: 21 start-page: 7210 year: 2013 end-page: 7215 article-title: Structural Study of Interaction between Brinzolamide and Dorzolamide Inhibition of Human Carbonic Anhydrases publication-title: Bioorg. Med. Chem – volume: 69 start-page: 358 year: 2009 end-page: 368 article-title: Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular PH publication-title: Cancer Res – volume: 4 start-page: 6746 year: 2019 end-page: 6756 article-title: Inhibitor–Polymer Conjugates as a Versatile Tool for Detection and Visualization of Cancer-Associated Carbonic Anhydrase Isoforms publication-title: ACS Omega – volume: 59 start-page: 5462 year: 2016 end-page: 5470 article-title: An Unusual Natural Product Primary Sulfonamide: Synthesis, Carbonic Anhydrase Inhibition, and Protein X-Ray Structures of Psammaplin C publication-title: J. Med. Chem – volume: 54 start-page: 1896 year: 2011 end-page: 1902 article-title: Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis publication-title: J. Med. Chem – volume: 27 start-page: 566 year: 2006 end-page: 573 article-title: Targeting Tumor-Associated Carbonic Anhydrase IX in Cancer Therapy publication-title: Trends Pharmacol. Sci – volume: 70 start-page: 1483 year: 2013 end-page: 1494 article-title: Sulfonamide Cross-Reactivity: Is There Evidence to Support Broad Cross-Allergenicity? publication-title: Am. J. Health. Syst. Pharm – volume: 4 start-page: 283 year: 1988 end-page: 293 article-title: Crystallographic Studies of Inhibitor Binding Sites in Human Carbonic Anhydrase II: A Pentacoordinated Binding of the SCN– Ion to the Zinc at High pH publication-title: Proteins – volume: 16 start-page: 1088 year: 2014 end-page: 1091 article-title: Asymmetric Domino Aza-Michael Addition/[3 + 2] Cycloaddition Reactions as a Versatile Approach to α,β,γ-Triamino Acid Derivatives publication-title: Org. Lett – volume: 7 start-page: 168 year: 2008 ident: 10.1177/2472555220918836_bib13 article-title: Carbonic Anhydrases: Novel Therapeutic Applications for Inhibitors and Activators publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd2467 – volume: 4 start-page: 6746 year: 2019 ident: 10.1177/2472555220918836_bib18 article-title: Inhibitor–Polymer Conjugates as a Versatile Tool for Detection and Visualization of Cancer-Associated Carbonic Anhydrase Isoforms publication-title: ACS Omega doi: 10.1021/acsomega.9b00596 – volume: 5 start-page: 3640 year: 2014 ident: 10.1177/2472555220918836_bib9 article-title: A Bivalent Small Molecule-Drug Conjugate Directed against Carbonic Anhydrase IX Can Elicit Complete Tumour Regression in Mice publication-title: Chem. Sci. doi: 10.1039/C4SC00685B – year: 2000 ident: 10.1177/2472555220918836_bib19 – volume: 61 start-page: 10860 year: 2018 ident: 10.1177/2472555220918836_bib23 article-title: 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.8b01504 – volume: 21 start-page: 7210 year: 2013 ident: 10.1177/2472555220918836_bib21 article-title: Structural Study of Interaction between Brinzolamide and Dorzolamide Inhibition of Human Carbonic Anhydrases publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2013.08.033 – volume: 89 start-page: 1067 year: 2003 ident: 10.1177/2472555220918836_bib4 article-title: Soluble Form of Carbonic Anhydrase IX (CA IX) in the Serum and Urine of Renal Carcinoma Patients publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6601264 – volume: 69 start-page: 358 year: 2009 ident: 10.1177/2472555220918836_bib5 article-title: Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular PH publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-08-2470 – volume: 60 start-page: 7075 year: 2000 ident: 10.1177/2472555220918836_bib3 article-title: Hypoxia-Inducible Expression of Tumor-Associated Carbonic Anhydrases publication-title: Cancer Res. – volume: 106 start-page: 16233 year: 2009 ident: 10.1177/2472555220918836_bib2 article-title: Crystal Structure of the Catalytic Domain of the Tumor-Associated Human Carbonic Anhydrase IX publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0908301106 – volume: 58 start-page: 12440 year: 2019 ident: 10.1177/2472555220918836_bib24 article-title: Photochemical C–H Amination of Ethers and Geminal Difunctionalization Reactions in One Pot publication-title: Angew. Chem. Int. Ed. doi: 10.1002/anie.201905209 – volume: 27 start-page: 566 year: 2006 ident: 10.1177/2472555220918836_bib6 article-title: Targeting Tumor-Associated Carbonic Anhydrase IX in Cancer Therapy publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2006.09.002 – volume: 11 start-page: 319 year: 2010 ident: 10.1177/2472555220918836_bib11 article-title: Acetazolamide and Sulfonamide Allergy: A Not So Simple Story publication-title: High Alt. Med. Biol. doi: 10.1089/ham.2010.1051 – volume: 4 start-page: 928 year: 2005 ident: 10.1177/2472555220918836_bib16 article-title: Acyclic Nucleoside Phosphonates: A Key Class of Antiviral Drugs publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd1877 – volume: 246 start-page: 2561 year: 1971 ident: 10.1177/2472555220918836_bib17 article-title: The Carbon Dioxide Hydration Activity of Carbonic Anhydrase I. Stop-Flow Kinetic Studies on the Native Human Isoenzymes B and C publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)62326-9 – volume: 5 start-page: e4068 year: 2017 ident: 10.1177/2472555220918836_bib8 article-title: An Update on Anticancer Drug Development and Delivery Targeting Carbonic Anhydrase IX publication-title: PeerJ doi: 10.7717/peerj.4068 – volume: 70 start-page: 1483 year: 2013 ident: 10.1177/2472555220918836_bib12 article-title: Sulfonamide Cross-Reactivity: Is There Evidence to Support Broad Cross-Allergenicity? publication-title: Am. J. Health. Syst. Pharm. doi: 10.2146/ajhp120291 – volume: 16 start-page: 1088 year: 2014 ident: 10.1177/2472555220918836_bib25 article-title: Asymmetric Domino Aza-Michael Addition/[3 + 2] Cycloaddition Reactions as a Versatile Approach to α,β,γ-Triamino Acid Derivatives publication-title: Org. Lett. doi: 10.1021/ol403660w – volume: 38 start-page: 65 year: 2019 ident: 10.1177/2472555220918836_bib1 article-title: The Role of Carbonic Anhydrase IX in Cancer Development: Links to Hypoxia, Acidosis, and Beyond publication-title: Cancer Metastasis Rev. doi: 10.1007/s10555-019-09799-0 – volume: 4 start-page: 283 year: 1988 ident: 10.1177/2472555220918836_bib22 article-title: Crystallographic Studies of Inhibitor Binding Sites in Human Carbonic Anhydrase II: A Pentacoordinated Binding of the SCN– Ion to the Zinc at High pH publication-title: Proteins doi: 10.1002/prot.340040407 – volume: 59 start-page: 5462 year: 2016 ident: 10.1177/2472555220918836_bib20 article-title: An Unusual Natural Product Primary Sulfonamide: Synthesis, Carbonic Anhydrase Inhibition, and Protein X-Ray Structures of Psammaplin C publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.6b00443 – volume: 63 start-page: 27 year: 1974 ident: 10.1177/2472555220918836_bib10 article-title: Structure Relationship for Binding of Sulfonamides and Penicillins to Bovine Serum Albumin by Fluorescence Probe Technique publication-title: J. Pharm. Sci. doi: 10.1002/jps.2600630107 – volume: 51 start-page: e10 year: 2018 ident: 10.1177/2472555220918836_bib14 article-title: Thermodynamic, Kinetic, and Structural Parameterization of Human Carbonic Anhydrase Interactions toward Enhanced Inhibitor Design publication-title: Q. Rev. Biophys. doi: 10.1017/S0033583518000082 – volume: 45 start-page: e10 year: 2017 ident: 10.1177/2472555220918836_bib15 article-title: DNA-Linked Inhibitor Antibody Assay (DIANA) for Sensitive and Selective Enzyme Detection and Inhibitor Screening publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkw853 – volume: 54 start-page: 1896 year: 2011 ident: 10.1177/2472555220918836_bib7 article-title: Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis publication-title: J. Med. Chem. doi: 10.1021/jm101541x |
| SSID | ssj0001763636 |
| Score | 2.1809158 |
| Snippet | The DNA-linked inhibitor antibody assay (DIANA) has been recently validated for ultrasensitive enzyme detection and for quantitative evaluation of enzyme... |
| SourceID | unpaywall proquest pubmed crossref sage |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1026 |
| Title | Identification of Novel Carbonic Anhydrase IX Inhibitors Using High-Throughput Screening of Pooled Compound Libraries by DNA-Linked Inhibitor Antibody Assay (DIANA) |
| URI | https://journals.sagepub.com/doi/full/10.1177/2472555220918836 https://www.ncbi.nlm.nih.gov/pubmed/32452709 https://www.proquest.com/docview/2406944990 https://journals.sagepub.com/doi/pdf/10.1177/2472555220918836 |
| UnpaywallVersion | publishedVersion |
| Volume | 25 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 2472-5560 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001763636 issn: 2472-5552 databaseCode: AKRWK dateStart: 19960201 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLagfQAeuF_KZTISqhha1iRObOcx2phWhqIKWtE9Rb5Fq4iSqk1A4ffwQ7ETt4VNGoI3Szm-JPlsH_uc8x0A3lDGAy4Fc7Dgwgk4Cx1KdUkoRAmPvECJlu0zwaez4MM8nFvfHBMLY7_g-tC4VekRtYu1md1LmY2sjXHkB0Rrwlpz0JsdpQjfBH1s7Es90J8lk_jcJJTTIo6R2ZWxuzNTXmniz23piq5p_bzugFt1sWTNd5bnv21DJ_e6XKvrlr3QeJ98PawrPfYfl7gd__sN74O7VkGFcYeoB-CGKh6C4aRjuG4O4HQXsLU-gEM42XFfN4_Azy7wN7M3gbDMYFJ-Uzk8YituWHhhXFw0cqX3Tjiew3FxseALk_AHtr4L0LidONMud9CyruBnYfyCzBPd0qQscyWhWcJMMij4cXPUh7yBx0nsmIO1Fti2qjurFryUDdQoZA18ezyOk3j_MZidvJ8enTo2EYQjEIkqh3pEaT3KFYoEmUBcZZKgzGeSCCbdCCkRSEkjqTjT-lOGkfSjIEOe70rKpWLoCegVZaGeASiIixWlWYCZF2hARjhUOPRDRXTtiMgBGG1wkArLkm6SdeSpZ4nRL_-aAdjf1lh2DCHXyL7eQCvV09jYZlihynqddhHI-vjpDsDTDnPb1pCxjhM3GoChwUy6QdA13bzbwvSvY3r-L8IvwG3fXDi03owvQa9a1eqV1soqvgf68dmnL2d7dg7-AmgBLQg |
| linkProvider | Unpaywall |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLagewAeuF_KTUZCFUPLmsSO7TxGG9OKUFSJVipPkW_RKqKkahNQ-D38UOzEbWGThuDNUo4vST7bxz7nfAeAt4wLLJTkHpFCeljwyGPMlKRGjIo4wFp2bJ8pOZ_jj4to4XxzbCyM-4KbY-tWZUbULdZ2dq9UPnY2xnGIqdGEjeZgNjvGELkJDoi1Lw3AwTydJl9sQjkj4lmZfZn4ezPllSb-3Jau6JrOz-sOuNWUK95-50Xx2zZ0dq_Ptbrp2Aut98nX46Y2Y_9xidvxv9_wPrjrFFSY9Ih6AG7o8iEYTXuG6_YIzvYBW5sjOILTPfd1-wj87AN_c3cTCKscptU3XcATvhaWhRcm5UWr1mbvhJMFnJQXS7G0CX9g57sArduJN-tzB62aGn6W1i_IPjEtTauq0AraJcwmg4Kftkd9KFp4miaePVgbgV2rprN6KSrVQoNC3sJ3p5MkTQ4fg_nZh9nJuecSQXgS0bj2WEC10aN8qSnOJRI6VxTlIVdUcuXHSEusFIuVFtzoTzlBKoxxjoLQV0wozdETMCirUj8DUFKfaMZyTHiADSBjEmkShZGmpnZM1RCMtzjIpGNJt8k6iixwxOiXf80QHO5qrHqGkGtk32yhlZlpbG0zvNRVs8n6CGRz_PSH4GmPuV1ryFrHqR8PwchiJtsi6Jpu3u9g-tcxPf8X4RfgdmgvHDpvxpdgUK8b_cpoZbV47ebeLwfEK2U |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+Novel+Carbonic+Anhydrase+IX+Inhibitors+Using+High-Throughput+Screening+of+Pooled+Compound+Libraries+by+DNA-Linked+Inhibitor+Antibody+Assay+%28DIANA%29&rft.jtitle=SLAS+discovery&rft.au=Tykvart%2C+Jan&rft.au=Navr%C3%A1til%2C+V%C3%A1clav&rft.au=Kugler%2C+Michael&rft.au=%C5%A0%C3%A1cha%2C+Pavel&rft.date=2020-10-01&rft.issn=2472-5552&rft.volume=25&rft.issue=9&rft.spage=1026&rft.epage=1037&rft_id=info:doi/10.1177%2F2472555220918836&rft.externalDBID=n%2Fa&rft.externalDocID=10_1177_2472555220918836 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2472-5552&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2472-5552&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2472-5552&client=summon |